# AAPL Fundamental Analysis Report (Teaching Sample Data)

**Analyst**: Fundamental Analyst (fundamental-analyst)
**Data Source**: `.team/demo-data/financials.csv` (FY2022-FY2025, 4 fiscal years, 14-field sample data), `.team/demo-data/stock_history.csv` (53-week weekly data)
**Sample Notes**: All figures are taken directly from the sample data file definitions (amounts in USD millions; ratios as percentages; ROE = net income / end-of-period equity; debt ratio = total liabilities / total assets; current ratio = current assets / current liabilities; PE = fiscal year-end price / diluted EPS for the fiscal year).

---

## 1. Revenue Growth Trend

| Fiscal Year | Revenue (USD mn) | YoY Growth | Fiscal Year-End Price (USD) |
|---|---|---|---|
| FY2022 | 394,328 | — | 142.0 |
| FY2023 | 383,285 | -2.80% | 171.0 |
| FY2024 | 391,035 | +2.02% | 233.0 |
| FY2025 | 410,450 | +4.97% | 262.0 |

- **Trend assessment**: After revenue declined 2.80% in FY2023, it recovered for two consecutive years in FY2024 (+2.02%) and FY2025 (+4.97%), hitting a new historical peak and returning to positive growth.
- The 3-year CAGR (FY2022→FY2025) is only **+1.34%** — a low absolute growth center, consistent with low single-digit steady growth rather than high growth.
- On the price side: fiscal year-end price rose from USD 142.0 to USD 262.0 (FY2022→FY2025, cumulative +84.5%). **Price gains far outpaced revenue/profit gains** — the rally was driven more by valuation expansion than earnings performance.

## 2. Earnings Quality (Gross Margin / Net Margin / ROE)

| Fiscal Year | Gross Margin | Net Margin | ROE |
|---|---|---|---|
| FY2022 | 43.31% | 25.31% | 196.9% |
| FY2023 | 44.13% | 25.31% | 156.1% |
| FY2024 | 46.21% | 24.62% | 162.6% |
| FY2025 | 46.66% | 24.44% | 151.8% |

- **Gross margin rose year over year**: from 43.31% to 46.66%, an improvement of about 3.35 percentage points over four years, reflecting product mix optimization / a higher share of high-margin services.
- **Net margin stable at high levels**: stable in the 24.4%-25.3% range across FY2022-FY2025, with a consistently high earnings conversion rate.
- **Extremely high ROE**: 151.8%-196.9% under the sample definition (reflecting a small end-of-period equity base + high-leverage operations). FY2025 net income of USD 100,180 million was the highest of the four fiscal years.

**Conclusion**: Earnings quality is excellent — structurally rising gross margin, ceiling-level stable net margin, and extremely high shareholder returns; however, ROE relies heavily on high leverage (debt ratio above 80%), which is a deduction in the quality score.

## 3. Financial Health (Debt Ratio / Liquidity)

| Fiscal Year | Debt-to-Assets Ratio | Current Ratio |
|---|---|---|
| FY2022 | 85.6% | 0.88 |
| FY2023 | 82.4% | 0.99 |
| FY2024 | 82.0% | 1.05 |
| FY2025 | 81.7% | 1.06 |

- **Debt ratio declined gradually** (85.6% → 81.7%), a favorable trend, but the **absolute level remains high (>80%)**, reflecting a heavily levered structure with limited financial flexibility.
- **Current ratio improved to the threshold**: recovered from 0.88 (FY2022) to 1.06 (FY2025), just crossing the 1.0 safety line — short-term solvency moved from "insufficient" to "basically adequate," but with a thin buffer.

## 4. Cash Flow Quality

| Fiscal Year | Operating Cash Flow (USD mn) | Net Cash Ratio (OCF / Net Income) |
|---|---|---|
| FY2022 | 122,151 | 1.22 |
| FY2023 | 110,543 | 1.14 |
| FY2024 | 118,254 | 1.21 |
| FY2025 | 115,019 | 1.15 |

- Operating cash flow exceeded USD 100,000 million in all four years, and the **net cash ratio exceeded 1 for 4 consecutive years (1.14-1.22)** — high "quality" of earnings, with real cash inflows backing reported net income. Cash flow is the most solid dimension in the sample data.

## 5. Valuation Assessment

| Fiscal Year | FY-End Price | FY-End PE | FY-End PB |
|---|---|---|---|
| FY2022 | 142.0 | 23.2x | 42.1x |
| FY2023 | 171.0 | 26.6x | 42.4x |
| FY2024 | 233.0 | 36.9x | 60.8x |
| FY2025 | 262.0 | 40.0x | 58.0x |

- Latest sample close (2026-09-14): **USD 276.11**, implying a PE of about **42.1x** on FY2025 EPS of 6.55 — **above the upper end** of the four-fiscal-year range (23.2-40.0x).
- Since FY2024, PE rose from 36.9x to 40.0x, with PB stable at a very high 58-61x — the valuation expansion (FY2023→FY2025 price +53%) far exceeded EPS growth (6.44→6.55, +1.7%), indicating that the price gains over the past two years were driven mainly by **valuation multiple expansion**.

### Fair Value Range Implied by Current Valuation (Qualitative + Quantitative)

- **Valuation anchor**: historical PE mid-point (simple average of four fiscal years) approx. **31.7x**; sample FY2026E EPS assumed around **USD 6.75-7.00** based on the revenue trend (+5% or so; an analyst assumption extrapolated from 6.55, not a sample-provided figure).
- **Sensitivity range** (FY2026E EPS mid-point 6.90):
  - Bearish (PE 30x): approx. **USD 207**
  - Base (PE 35x): approx. **USD 242**
  - Bullish (PE 40x): approx. **USD 276**
- **Qualitative judgment**: The current price of USD 276.11 sits exactly at the "bullish 40x" level, at the upper edge of the historical valuation band; at the base 35x the fair-value mid-point is roughly **USD 240**, implying a **13-15% premium** of the current price over the fair-value mid-point. The market has priced in the optimistic scenario of "continued earnings growth + sustained high valuation," leaving **insufficient margin of safety**.

---

## 6. Company Quality Score (out of 100)

| Component | Max Score | Score | Basis (sample data) |
|---|---|---|---|
| Revenue growth trend | 20 | 12 | Low single-digit growth, CAGR only 1.34%, but FY2025 recovered +4.97% |
| Profitability | 25 | 23 | Gross margin rose to 46.66% over four years, net margin stable at 24%+, ROE 151.8%+ |
| Financial health | 20 | 11 | Debt ratio 81.7% on the high side, current ratio 1.06 barely adequate |
| Cash flow quality | 20 | 18 | Net cash ratio >1 for 4 consecutive years (1.14-1.22) |
| Valuation level | 15 | 7 | Implied PE 42x at historical upper edge, no margin of safety |
| **Total** | **100** | **72** | **Rating: Good (solid quality, expensive valuation)** |

## 7. Bullish Thesis (3+ points)

1. **Revenue back in growth**: FY2025 revenue of USD 410,450 million set a four-year high, up +4.97% YoY, with two consecutive increases after the FY2023 trough.
2. **Earnings quality keeps improving**: Gross margin rose for four straight years to 46.66% (+3.35pct structural improvement), net margin stable above 24.4%, ROE maintaining ultra-high capital returns above 150%.
3. **Extremely high cash-flow quality**: Operating cash flow exceeded USD 100,000 million for four consecutive years, with a full-period net cash ratio >1.14 — earnings backed by real cash, almost no "paper profits."
4. **Improving financial structure at the margin**: Debt-to-assets ratio declined year by year from 85.6% to 81.7%, current ratio recovered from 0.88 to 1.06 above the safety line, with directional repair of the solvency buffer.

## 8. Risk Warnings (3 items)

1. **Valuation overhang risk (primary)**: Implied PE of 42x and PB of 58x are at historical highs, while EPS growth is only single digits — earnings and valuation are mismatched. If growth disappoints or risk appetite cools, there is large room for de-rating (a base-case reversion to 35x implies roughly 13% downside).
2. **Low revenue growth center**: The 3-year CAGR is only 1.34%; if the next product cycle (new categories not covered in the sample) fails to ramp up, the high valuation lacks fundamental support.
3. **High leverage + thin liquidity buffer**: Debt ratio of 81.7% remains elevated and the current ratio of 1.06 is a thin buffer; financial flexibility is constrained in a rising-rate or volatile cash-flow environment.

---

*This report is based on locally generated teaching sample data (including analyst extrapolation assumptions), not real-time quotes or real financial data; all conclusions are for demonstrating the multi-agent research workflow only.*<br>
**Teaching demonstration only; not investment advice.**
